Zacks Releases Four Powerful ''Buy'' Stocks: Kadant, Littelfuse, Pharmaceutical Products Development and Dana Holding Corporation

Mar 01, 2011, 09:30 ET from Zacks Investment Research, Inc.

CHICAGO, March 1, 2011 /PRNewswire/ -- Four free stock picks are being made available today on Zacks.com. The industry's leading independent research firm highlights one Zacks #1 Rank Strong Buy or a Zacks #2 Rank Buy stock for each of the four main styles of investing: Aggressive Growth, Growth & Income, Momentum, and Value.

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

The four highlighted picks are: Kadant Inc. (NYSE: KAI), Littelfuse, Inc. (Nasdaq: LFUS), Pharmaceutical Products Development Ltd. (Nasdaq: PPDI) and Dana Holding Corporation (NYSE: DAN).

Today, Zacks is promoting its ''Buy'' stock recommendations. Four daily picks are offered free at http://at.zacks.com/?id=88

Zacks #1 Rank Stocks have nearly tripled the S&P 500 since 1988, producing an average annual return of +26%. Performance has been notable even during volatile and down times. For example, during the last bear market, 2000-2002, the market tumbled -37.6% – but Zacks #1 Rank stocks gained +43.8%.

Here is a summary of today's selected stocks that are now highly rated by Zacks:

Aggressive Growth – Kadant Inc. (NYSE: KAI)

Kadant Inc. easily topped expectations in its most recent quarterly report. The period ended a great year for the company and things should continue to improve in 2011.

Zacks Guide to Aggressive Growth Investing (free!): http://at.zacks.com/?id=4309

Growth & Income – Littelfuse, Inc. (Nasdaq: LFUS)

Littelfuse, Inc. has a lot going for it lately. The company recently delivered its third consecutive positive earnings surprise driven by strong sales growth across each business segment and geographical region.

Zacks Guide to Growth & Income Investing (free!): http://at.zacks.com/?id=4310

Momentum – Pharmaceutical Products Development Ltd. (Nasdaq: PPDI)

Pharmaceutical Products Development Ltd. recently hit a new multi-year high above $30 before reporting strong Q4 results in early February that came in ahead of expectations. With estimates on the rise and a bullish growth projection, this Zacks # 1 rank stock offers a twist of healthcare to the momentum faction.

Zacks Guide to Momentum Investing (free!): http://at.zacks.com/?id=4311

Value – Dana Holding Corporation (NYSE: DAN)

The auto industry has staged a remarkable worldwide recovery. Dana Holding Corporation is expected to see double digit earnings growth in both 2011 and 2012. Shares have value, trading with a Price-to-Sales ratio of just 0.4.

Zacks Guide to Value Investing (free!): http://at.zacks.com/?id=4312

How to Regularly Access Top Zacks Rank Picks for Free:  http://at.zacks.com/?id=7154

Underlying the four free stock picks is a simple truth that first appeared in a Financial Analysts Journal article published in 1979. Leonard Zacks, a Ph.D. in Mathematics from M.I.T. found that "earnings estimate revisions are the most powerful force impacting stock prices."  Zacks #1 Rank is awarded to a stock when analysts sharply upgrade their estimates of what the company will earn.

Today, Zacks is promoting its stock recommendations by offering four daily picks free to those who register at http://at.zacks.com/?id=7155  

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. The company continually processes stock reports issued by 3,000 analysts from 150 brokerage firms.  It monitors more than 200,000 earnings estimates, looking for changes.

Then, when changes are discovered, they're applied to help assign more than 4,400 stocks into five Zacks Rank categories: #1 Strong Buy, #2 Buy, #3 Hold, #4 Sell, and #5 Strong Sell. This proprietary stock-picking system continues to outperform the market by a nearly 3-to-1 margin.

More Free Stock Picks

Each weekday, new Zacks #1 Rank or Zacks #2 Rank stock picks are released on the free email newsletter, Profit from the Pros. Investors are invited to register for their free subscription at http://at.zacks.com/?id=91

Follow us on Twitter:  http://twitter.com/zacksresearch

Join us on Facebook:  http://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Zacks.com

Aggressive Growth Stocks:

Contact: Bill Wilton

Phone: 312-265-9277


or


Growth & Income Stocks:

Contact: Rob Plaza

Phone: 312-265-9442


or


Momentum Stocks:

Contact: Michael Vodicka

Phone: 312-265-9226


or


Value Stocks:

Contact: Tracey Ryniec

Phone: 312-265-9232


Email: pr@zacks.com

Visit: www.zacks.com



Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

SOURCE Zacks Investment Research, Inc.



RELATED LINKS

http://www.zacks.com